Literature DB >> 14709849

Hypercholesterolemia and obesity in adult patients with hypopituitarism: a report of a nation-wide survey in Japan.

Yoshio Murakami1, Yuzuru Kato.   

Abstract

Dyslipidemia and obesity are common in adult patients with hypopituitarism. Possible contributions of age, sex and hormone deficiencies to hypercholesterolemia and obesity in adult hypopituitary patients were analyzed in 1, 272 Japanese cases based on a database of a national survey on adult hypopituitarism. In patients on routine hormone replacement therapy, 30.5% of male and 40.7% of female subjects were considered hypercholesterolemic. In univariate analysis, hypercholesterolemia was more prevalent in female, aged, untreated Gn-deficient and TSH-deficient groups. In multivariate analysis, sex of female, age older than 40 yr and TSH deficiency were the independent contributing factors to hypercholesterolemia. Obesity (body mass index (BMI) > or = 25 kg/m2) was more prevalent in male, TSH-deficient and ADH-deficient groups. Severe obesity (BMI > or = 30) was observed in high prevalence in the youngest group. These findings suggest that hypercholesterolemia and obesity were prevalent in different age and gender groups in Japanese adult patients with hypopituitarism. Insufficient replacement of thyroid hormone and possibly gonadotropin deficiency might contribute to hypercholesterolemia. In contrast, hypothalamic dysfunction as well as hormone deficiencies might play roles in obesity in these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14709849     DOI: 10.1507/endocrj.50.759

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  3 in total

1.  High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors.

Authors:  Shirui Wang; Yuelun Zhang; Xiang Zhou; Kun Zhang; Yi Zhang; Yong Yao; Shi Chen; Hui Pan; Huijuan Zhu
Journal:  Pituitary       Date:  2022-09-10       Impact factor: 3.599

2.  Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence.

Authors:  Salvatore Giovinazzo; Soraya Puglisi; Oana R Cotta; Angela Alibrandi; Tommaso Aversa; Laura Cannavò; Francesco Ferraù; Salvatore Cannavò
Journal:  Pituitary       Date:  2021-01-19       Impact factor: 4.107

3.  Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency.

Authors:  Hitoshi Kohno; Toshiaki Tanaka; Kenji Fujieda; Kazuo Chihara; Yoshiki Seino; Minoru Irie; Kazue Takano
Journal:  Clin Pediatr Endocrinol       Date:  2012-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.